Related Experiment Video
Updated: Aug 10, 2026

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
[Association of matrix metalloproteinase-2 activity with cell proliferation and growth in ameloblastoma]
Bin Zhang1, Hong-Zhang Huang, Qian Tao
1Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Objective:
To investigate the relationship between matrix metalloproteinase-2 (MMP-2)activity and cell proliferation, growth and invasion of ameloblastoma.
Methods:
The cells and xenograft of ameloblastoma were treated with MMP-2 inhibitor Ro31-9790 and the effects of Ro31-9790 on the cell proliferation and growth of ameloblastoma were observed. Primary culture in vitro, subcapsular kidney xenograft in vivo, MTT assay, flow cytometry, neoplastic volume measurement and histochemistry were employed to study the effects of cell proliferation and growth produced by Ro31-9790.
Results:
There was no significant different in cell proliferation at same interval among several groups (P > 0.05). The ratio of G0/G1 stage, G2/M stage and apoptotic cells didn't increase following increased Ro31-9790, and the ratio of S stage cells also didn't reduce following increased Ro31-9790. The tumor volume and its increase in treatment group were significant less than those in control group.
Conclusion:
Ro31-9790 does not influence proliferation of ameloblastoma cells in vitro, but it can effectively inhibit the ameloblastoma growth in vivo. MMP-2 activity has no relationship to proliferation of ameloblastoma cells, but it can contribute to the ameloblastoma growth and may be a reason of invasion in ameloblastoma.
Insights
Matrix metalloproteinase-2 (MMP-2) inhibitor Ro31-9790 did not affect ameloblastoma cell proliferation in vitro. However, it significantly inhibited ameloblastoma tumor growth in vivo, suggesting MMP-2 contributes to tumor progression.
Area of Science:
- Oral Pathology
- Oncology
- Biochemistry
Background:
- Ameloblastoma is a common odontogenic tumor with a high recurrence rate.
- Matrix metalloproteinase-2 (MMP-2) is implicated in tumor growth and invasion.
- Understanding MMP-2's role is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the relationship between MMP-2 activity and ameloblastoma cell proliferation, growth, and invasion.
- To evaluate the efficacy of an MMP-2 inhibitor, Ro31-9790, on ameloblastoma.
- To determine if MMP-2 is a viable therapeutic target for ameloblastoma.
Main Methods:
- Ameloblastoma cells and xenografts were treated with MMP-2 inhibitor Ro31-9790.
- In vitro studies included MTT assay and flow cytometry to assess cell proliferation and apoptosis.
- In vivo studies involved subcapsular kidney xenografts, measuring neoplastic volume and histochemistry.
Main Results:
- Ro31-9790 did not significantly alter ameloblastoma cell proliferation in vitro.
- No significant changes were observed in cell cycle distribution or apoptosis ratios.
- Tumor volume and growth were significantly reduced in the Ro31-9790 treatment group compared to controls.
Conclusions:
- MMP-2 activity is not directly related to ameloblastoma cell proliferation.
- MMP-2 inhibition effectively suppresses ameloblastoma tumor growth in vivo.
- MMP-2 may play a role in ameloblastoma growth and invasion, representing a potential therapeutic target.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...